http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100439659-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2001-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100439659-B1 |
| titleOfInvention | Transdermal delivery system for tulobuterol |
| abstract | The present invention is a tulobuterol as an active ingredient; Polyglyceryl Oleque, PEG-8 Glyceryl Capriate / Caprate (Labrasol), PEG-8 Glyceryl Linoleate (Labrafil 2609), Sorbitan Fatty Acid Ester (Span), Polyoxyethylene-Sorbitan One or two or more absorption promoters selected from the group consisting of fatty acid esters (Tween); Alkanolamines as alkalizing agents; And a matrix composed of one or two or more of an acrylate polymer having a hydrophilic polymer grafted with a hydrophilic polymer and a hydroxyl group as a matrix substrate, and a patch for percutaneous absorption for percutaneous absorption. The present invention is very effective for sustained long-term sustained release of the drug tulobuterol, and is effective in producing patches. |
| priorityDate | 2001-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.